These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9838689)

  • 1. Establishment of chimerism in donors by intraportal injection of recipient-type bone marrow cells with concomitant administration of FK 506 before liver transplantation prolongs liver allograft survival in rats.
    Sanada O; Sumimoto R; Fukuda Y; Hoshino S; Nishihara M; Kaneda K; Ito H; Asahara T; Dohi K
    Transplant Proc; 1998 Nov; 30(7):3860-1. PubMed ID: 9838689
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishment of chimerism in donor liver with recipient-type bone marrow cells prior to liver transplantation produces marked suppression of allograft rejection in rats.
    Sanada O; Fukuda Y; Sumimoto R; Hoshino S; Nishihara M; Kaneda K; Asahara T; Dohi K
    Transpl Int; 1998; 11 Suppl 1():S174-8. PubMed ID: 9664973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric liver established by recipient type bone marrow cell transplantation to donor before to liver transplantation produces marked suppression of allograft rejection in rats.
    Sanada O; Sumimoto R; Fukuda Y; Kaneda K; Ito H; Asahara T; Dohi K
    Transplant Proc; 1999; 31(1-2):704-6. PubMed ID: 10083304
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats.
    Tashiro H; Shintaku S; Fudaba Y; Yamamoto H; Shibata S; Mizunuma K; Okimasa S; Marubayashi S; Fukuda Y; Dohi K; Asahara T
    Transplant Proc; 2000 Nov; 32(7):2363-4. PubMed ID: 11120201
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of donor-specific hyporeactivity in augmented microchimerism in rat liver transplantation followed by donor bone marrow.
    Tashiro H; Fukuda Y; Kimura A; Hoshino S; Shintaku S; Ohdan H; Miyata H; Dohi K
    Transplant Proc; 1997; 29(1-2):1196-7. PubMed ID: 9123269
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation.
    Ohdan H; Fukuda Y; Shintaku S; Miyata Y; Tashiro H; Hoshino S; Sumimoto R; Asahara T; Kimura A; Dohi K
    Transplant Proc; 1997; 29(1-2):925-7. PubMed ID: 9123589
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of micro-chimerism in inducing immunological tolerance by intraportal injection of donor spleen cells in rats.
    Nagano H; Tanigawa T; Yoshida T; Ota H; Akagi K; Hasuike Y; Gotoh M; Nishisho I; Monden M
    Cell Transplant; 1995; 4 Suppl 1():S59-60. PubMed ID: 7795908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer.
    Muramatsu K; Valenzuela RG; Bishop AT
    J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR-flow analysis used to detect the levels of chimerism in peripheral blood of bone-marrow infused organ allograft recipients at the time of rejection episodes.
    Garcia-Morales R; Esquenazi V; Carreno M; Karatzas T; Gomez C; Cirocco R; Zucker K; Fuller L; Alamo A; Temple D; Fernandez H; Ciancio G; Burke G; Webb M; Nery J; Roth D; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1997 Jun; 29(4):2179-80. PubMed ID: 9193578
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats.
    Yano K; Fukuda Y; Sumimoto R; Ito H; Sumimoto K; Dohi K
    Transpl Int; 1994; 7 Suppl 1():S187-93. PubMed ID: 11271200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and chimerism in liver transplantation.
    Fung JJ
    Transplant Proc; 1997 Nov; 29(7):2817-8. PubMed ID: 9365574
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
    Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
    Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein.
    Nakao A; Yagi T; Sun DS; Matsukawa H; Endo A; Okada Y; Sadamori H; Inagaki M; Matsuno T; Tanaka N
    Transplant Proc; 2000 Sep; 32(6):1318-9. PubMed ID: 10995965
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
    Nardo B; Valdivia LA; Catena F; Cavallari G; Demetris AJ; Rao AS; Fung JJ; Starzl TE; Cavallari A
    Transplant Proc; 2000 Dec; 32(8):2710-2. PubMed ID: 11134771
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients.
    Zeevi A; Pavlick M; Lombardozzi S; Banas R; Rao AS; Fontes P; Demetris AJ; Shapiro R; Jordan M; Dodson F
    Transplant Proc; 1995 Feb; 27(1):213-5. PubMed ID: 7533388
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow.
    Terakura M; Murase N; Demetris AJ; Ye Q; Thomson AW; Starzl TE
    Transplantation; 1998 Aug; 66(3):350-7. PubMed ID: 9721804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fate of donor cells in vascularized bone grafts: identification of systemic chimerism by the polymerase chain reaction.
    Muramatsu K; Bishop AT; Sunagawa T; Valenzuela RG
    Plast Reconstr Surg; 2003 Feb; 111(2):763-72; discussion 773-4. PubMed ID: 12560697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-party passenger leukocytes prolong liver allograft survival.
    Kreisel D; Petrowsky H; Krasinskas AM; Szeto WY; Krupnick AS; McLean AD; Popma SH; Moore JS; Rosengard BR
    Transplant Proc; 2001; 33(1-2):171-2. PubMed ID: 11266764
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of high-level microchimerism with graft acceptance in rat liver transplantation.
    Tashiro H; Fukuda Y; Kimura A; Hoshino S; Furukawa M; Shintaku S; Dohi K
    Transplant Proc; 1997; 29(1-2):1230-1. PubMed ID: 9123287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.